comparemela.com
Latest Breaking News On - Prnewswire jw cayman therapeutics co - Page 1 : comparemela.com
JW Therapeutics: Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress
SHANGHAI, May 30, 2024 /PRNewswire/ JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology
China
Hong-kong
Shanghai
Markj-gilbert
A-bristol-myers-squibb
Ltd-the-company
Prnewswire-jw-cayman-therapeutics-co
China-national-medical-products-administration
National-significant-new-drug-development-program
Rheumatology-congress
Clearing-limited-hkex
European-alliance-of-associations
vimarsana © 2020. All Rights Reserved.